AG
HBIO icon

Algert Global’s Harvard Bioscience HBIO Stock Holding History

Algert Global’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,093
Closed -$90K – 1179
2023
Q3 		$90K Sell
2,093
-419
-17% -$19.3K ﹤0.01% 1038
2023
Q2 		$138K Buy
+2,512
New +$138K 0.01% 1015
2022
Q4 		– Sell
-1,487
Closed -$38K – 1188
2022
Q3 		$38K Hold
1,487
– – ﹤0.01% 1144
2022
Q2 		$54K Buy
1,487
+176
+13% +$7.94K ﹤0.01% 1149
2022
Q1 		$81K Buy
+1,311
New +$77.5K 0.01% 1117
2020
Q1 		– Sell
-2,596
Closed -$79K – 457
2019
Q4 		$79K Sell
2,596
-3,706
-59% -$107K 0.02% 356
2019
Q3 		$194K Buy
6,302
+1,189
+23% +$29.6K 0.07% 282
2019
Q2 		$102K Sell
5,113
-2,353
-32% -$68.9K 0.04% 317
2019
Q1 		$322K Sell
7,466
-29,842
-80% -$1.08M 0.18% 178
2018
Q4 		$1.19M Sell
37,308
-5,034
-12% -$198K 0.33% 102
2018
Q3 		$2.22M Buy
42,342
+13,006
+44% +$730K 0.48% 64
2018
Q2 		$1.57M Buy
29,336
+3,158
+12% +$162K 0.33% 120
2018
Q1 		$1.31M Buy
26,178
+7,436
+40% +$333K 0.25% 146
2017
Q4 		$618K Buy
18,742
+3,833
+26% +$129K 0.15% 213
2017
Q3 		$559K Buy
14,909
+3,527
+31% +$104K 0.13% 215
2017
Q2 		$290K Hold
11,382
– – 0.08% 249
2017
Q1 		$296K Buy
11,382
+1,712
+18% +$49.3K 0.08% 264
2016
Q4 		$295K Buy
9,670
+4,803
+99% +$122K 0.08% 265
2016
Q3 		$132K Buy
+4,867
New +$135K 0.04% 350

Other funds holding HBIO

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Algert Global's HBIO Position: Q4 2023 in Review

Algert Global sold out of Harvard Bioscience (HBIO) in Q4 2023, closing a stake of 2,093 shares — an estimated $90K sold.

Algert Global first reported a position in HBIO in Q3 2016 and held it in 19 quarters. The position peaked at $2.22M in Q3 2018. 93 funds tracked by Wall St. Rank hold HBIO as of Q4 2023.

  • Algert Global reported no remaining Harvard Bioscience position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 2,093 Harvard Bioscience shares in Q4 2023, an estimated $90K.
  • Algert Global first reported a position in Harvard Bioscience in Q3 2016 and held it in 19 quarters.
  • Algert Global's Harvard Bioscience position peaked at $2.22M in Q3 2018.
  • 93 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.